GLP-1 Receptor Agonists Beyond Diabetes: 7 Powerful Ways Semaglutide and Tirzepatide Are Reshaping Medicine
GLP-1 receptor agonists like semaglutide and tirzepatide were designed for type 2 diabetes, but emerging research reveals they may protect the heart, brain, kidneys, and liver. Discover the science behind these landmark drugs and what they mean for the future of medicine.